{"transactions":[{"id":760174,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":9091,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"This option represents a right to purchase a total of 9,091 shares of the Issuer's common stock, one-half of which will become fully vested and exercisable on May 26, 2027, with the remaining shares becoming fully vested and exercisable on May 26, 2028, in each case, subject to the reporting person's continued employment with the Issuer."}],"balance_after":9091,"derivative":{"exercise_price":3,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":9091},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760173,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":24899,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer."}],"balance_after":24899,"derivative":{"exercise_price":3,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":24899},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760172,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":16061,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer."}],"balance_after":16061,"derivative":{"exercise_price":3,"expiration_date":"2032-04-18","underlying":"Common Stock","underlying_shares":16061},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760171,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":15002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer."}],"balance_after":15002,"derivative":{"exercise_price":3,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":15002},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760170,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":51509,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"Represents a right to purchase shares of the Issuer's common stock, which will become fully vested on May 26, 2027, subject to the reporting person's continued employment with the Issuer."}],"balance_after":51509,"derivative":{"exercise_price":3,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":51509},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760169,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":24545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"This option represents a right to purchase a total of 24,545 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 16, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":30.01,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":24545},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760168,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":49798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"This option represents a right to purchase a total of 49,798 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":49798},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760167,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28910,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"This option represents a right to purchase a total of 28,910 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":13.12,"expiration_date":"2032-04-18","underlying":"Common Stock","underlying_shares":28910},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760166,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27003,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"This option represents a right to purchase a total of 27,003 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":19.05,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":27003},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760165,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":62.32,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760164,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on August 3, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":24.82,"expiration_date":"2030-08-03","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760163,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option represents a right to purchase a total of 2,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 10, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":23.89,"expiration_date":"2030-02-10","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760162,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":22.72,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760161,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, 3,336 of which will become fully vested and exercisable on September 2, 2020, with the remaining 6,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":10.85,"expiration_date":"2029-09-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760160,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, 6,672 of which will become fully vested and exercisable on January 28, 2020, with the remaining 13,328 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":14.56,"expiration_date":"2029-01-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760159,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, 3,336 of which will become fully vested and exercisable on June 25, 2019, with the remaining 6,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":20.61,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":760158,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-28T20:33:19.000Z","date":"2026-05-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 26, 2026, the Issuer cancelled, pursuant to an option exchange program, eligible out-of-the-money stock options tendered by the Reporting Person, in exchange for the issuance of replacement stock options with an exercise price of $3.00, which was the closing price of the Issuer's Common Stock on the Nasdaq Global Market on May 26, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, 3,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 6,664 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":0,"derivative":{"exercise_price":18.75,"expiration_date":"2028-03-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-26-023153","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126023153/form4.xml","form_type":"4"}},{"id":767966,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-21T20:06:03.000Z","date":"2026-05-19","kind":"sale","planned":false,"acquired":false,"shares":384,"price":3.014,"value":1157.376,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":89780,"source":{"system":"sec-edgar","filing":"0001140361-26-022445","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126022445/form4.xml","form_type":"4"}},{"id":779178,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-14T20:16:09.000Z","date":"2026-05-13","kind":"sale","planned":false,"acquired":false,"shares":855,"price":3.606,"value":3083.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":90164,"source":{"system":"sec-edgar","filing":"0001140361-26-021305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126021305/form4.xml","form_type":"4"}},{"id":890679,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-20T21:31:44.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":1157,"price":3.338,"value":3862.066,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":91019,"source":{"system":"sec-edgar","filing":"0001140361-26-006330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126006330/form4.xml","form_type":"4"}},{"id":896801,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-18T22:38:28.000Z","date":"2026-02-13","kind":"sale","planned":false,"acquired":false,"shares":3726,"price":3.312,"value":12340.512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":92176,"source":{"system":"sec-edgar","filing":"0001140361-26-006045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126006045/form4.xml","form_type":"4"}},{"id":905196,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-13T21:05:27.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":45018,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 45,018 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":45018,"derivative":{"exercise_price":3.24,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":45018},"source":{"system":"sec-edgar","filing":"0001140361-26-005411","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126005411/form4.xml","form_type":"4"}},{"id":905195,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-13T21:05:27.000Z","date":"2026-02-11","kind":"grant","planned":false,"acquired":true,"shares":29982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":95902,"source":{"system":"sec-edgar","filing":"0001140361-26-005411","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036126005411/form4.xml","form_type":"4"}},{"id":992507,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-20T21:05:36.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":1086,"price":2.983,"value":3239.538,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":65920,"source":{"system":"sec-edgar","filing":"0001140361-25-042857","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125042857/form4.xml","form_type":"4"}},{"id":1017609,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-16T20:01:50.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":558,"price":3.975,"value":2218.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":67006,"source":{"system":"sec-edgar","filing":"0001140361-25-038302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125038302/form4.xml","form_type":"4"}},{"id":1017608,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-16T20:01:50.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":3005,"price":3.97,"value":11929.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":67564,"source":{"system":"sec-edgar","filing":"0001140361-25-038302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125038302/form4.xml","form_type":"4"}},{"id":1017607,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-16T20:01:50.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":5514,"price":3.965,"value":21863.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":70569,"source":{"system":"sec-edgar","filing":"0001140361-25-038302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125038302/form4.xml","form_type":"4"}},{"id":1017606,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-16T20:01:50.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":19841,"price":3.96,"value":78570.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."}],"balance_after":76083,"source":{"system":"sec-edgar","filing":"0001140361-25-038302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125038302/form4.xml","form_type":"4"}},{"id":1044762,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-09T20:22:27.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on September 8, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":95924,"source":{"system":"sec-edgar","filing":"0001140361-25-034431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125034431/form4.xml","form_type":"4"}},{"id":1060240,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-20T21:00:24.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":361,"price":2.996,"value":1081.556,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":55924,"source":{"system":"sec-edgar","filing":"0001140361-25-032092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125032092/form4.xml","form_type":"4"}},{"id":1060239,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-20T21:00:24.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":699,"price":3.065,"value":2142.435,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":56285,"source":{"system":"sec-edgar","filing":"0001140361-25-032092","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125032092/form4.xml","form_type":"4"}},{"id":1063897,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-18T20:35:03.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":7043,"price":3.019,"value":21262.817,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":56984,"source":{"system":"sec-edgar","filing":"0001140361-25-031761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125031761/form4.xml","form_type":"4"}},{"id":1137162,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-22T20:05:48.000Z","date":"2025-05-20","kind":"sale","planned":false,"acquired":false,"shares":357,"price":6.446,"value":2301.222,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":64027,"source":{"system":"sec-edgar","filing":"0001140361-25-020163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125020163/form4.xml","form_type":"4"}},{"id":1140433,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-20T20:05:47.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":655,"price":6.528,"value":4275.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":64384,"source":{"system":"sec-edgar","filing":"0001140361-25-019902","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125019902/form4.xml","form_type":"4"}},{"id":1166391,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-24T20:06:24.000Z","date":"2025-04-22","kind":"sale","planned":false,"acquired":false,"shares":718,"price":7.158,"value":5139.444,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":65039,"source":{"system":"sec-edgar","filing":"0001140361-25-015426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125015426/form4.xml","form_type":"4"}},{"id":1246154,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-25T21:01:55.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":2737,"price":10.58,"value":28957.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":65757,"source":{"system":"sec-edgar","filing":"0001140361-25-005845","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125005845/form4.xml","form_type":"4"}},{"id":1269576,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T21:01:30.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":29920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 29,920 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":29920,"derivative":{"exercise_price":9.88,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":29920},"source":{"system":"sec-edgar","filing":"0001140361-25-004292","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125004292/form4.xml","form_type":"4"}},{"id":1269575,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-13T21:01:30.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":20080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":68494,"source":{"system":"sec-edgar","filing":"0001140361-25-004292","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125004292/form4.xml","form_type":"4"}},{"id":1294431,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-27T21:16:03.000Z","date":"2025-01-23","kind":"sale","planned":false,"acquired":false,"shares":896,"price":10.38,"value":9300.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":48414,"source":{"system":"sec-edgar","filing":"0001140361-25-002069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036125002069/form4.xml","form_type":"4"}},{"id":1352672,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-25T21:05:19.000Z","date":"2024-11-21","kind":"sale","planned":false,"acquired":false,"shares":1224,"price":13.054,"value":15978.096,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":49310,"source":{"system":"sec-edgar","filing":"0001140361-24-047757","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124047757/form4.xml","form_type":"4"}},{"id":1377138,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-11-04T21:05:26.000Z","date":"2024-10-31","kind":"sale","planned":false,"acquired":false,"shares":917,"price":16.625,"value":15245.125,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include Restricted Stock Units (\"RSUs\") that convert to common stock on a one-for-one basis."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":50534,"source":{"system":"sec-edgar","filing":"0001140361-24-045099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124045099/form4.xml","form_type":"4"}},{"id":1427635,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-20T20:26:54.000Z","date":"2024-08-16","kind":"sale","planned":false,"acquired":false,"shares":1064,"price":18.504,"value":19688.256,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":51451,"source":{"system":"sec-edgar","filing":"0001140361-24-037934","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124037934/form4.xml","form_type":"4"}},{"id":1449356,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-24T20:05:39.000Z","date":"2024-07-22","kind":"sale","planned":false,"acquired":false,"shares":812,"price":23.015,"value":18688.18,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":52515,"source":{"system":"sec-edgar","filing":"0001140361-24-034029","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124034029/form4.xml","form_type":"4"}},{"id":1508979,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-05-20T20:36:21.000Z","date":"2024-05-16","kind":"sale","planned":false,"acquired":false,"shares":1079,"price":23.35,"value":25194.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":53327,"source":{"system":"sec-edgar","filing":"0001140361-24-026881","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124026881/form4.xml","form_type":"4"}},{"id":1536183,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-04-24T20:06:08.000Z","date":"2024-04-22","kind":"sale","planned":false,"acquired":false,"shares":833,"price":22.87,"value":19050.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":54406,"source":{"system":"sec-edgar","filing":"0001140361-24-021703","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124021703/form4.xml","form_type":"4"}},{"id":1561875,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T00:54:59.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":true,"shares":11067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F2","text":"One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2903},"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561874,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T00:54:59.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":true,"shares":14310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F3","text":"Vests in full on August 12, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14310},"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561873,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T00:54:59.000Z","date":"2022-04-18","kind":"other","planned":false,"acquired":true,"shares":7932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F2","text":"One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7932},"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561872,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T00:54:59.000Z","date":"2022-02-14","kind":"other","planned":false,"acquired":true,"shares":2903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F2","text":"One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2903},"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561871,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-26T00:54:59.000Z","date":"2024-03-21","kind":"sale","planned":false,"acquired":false,"shares":2490,"price":28.104,"value":69978.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The shares of common stock were sold by the Reporting Person in order to pay tax obligations in connection with the vesting of RSUs over the course of 2023."},{"field":"kind","element":"transactionCoding","label":"F4","text":"The shares of common stock were sold by the Reporting Person in order to pay tax obligations in connection with the vesting of RSUs over the course of 2023."}],"balance_after":55239,"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561870,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-26T00:54:59.000Z","date":"2023-02-14","kind":"other","planned":false,"acquired":true,"shares":11067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F2","text":"One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":57729,"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561869,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-26T00:54:59.000Z","date":"2022-08-12","kind":"other","planned":false,"acquired":true,"shares":14310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F3","text":"Vests in full on August 12, 2025."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":46662,"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561868,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-26T00:54:59.000Z","date":"2022-04-18","kind":"other","planned":false,"acquired":true,"shares":7932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F2","text":"One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":32352,"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1561867,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-26T00:54:59.000Z","date":"2022-02-14","kind":"other","planned":false,"acquired":true,"shares":2903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."},{"field":"security","element":"securityTitle","label":"F2","text":"One-third (1/3) of such RSUs vest upon the one-year anniversary of the grant, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that are settled in shares of common stock on a one-for-one basis upon vesting.  These RSUs were initially reported on Table II and, in accordance with SEC guidance, are now being reported on Table I. This Form 4 updates the filing history of the Reporting Person to include such RSUs on Table I and does not reflect the award of new RSUs."}],"balance_after":24420,"source":{"system":"sec-edgar","filing":"0001140361-24-015101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124015101/form4.xml","form_type":"4"}},{"id":1603093,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T23:54:22.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":12.55,"value":125500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 10,000 shares of the Issuer's Common Stock, one-third of which became fully vested and exercisable on January 8, 2019, with the remaining two-thirds vesting in equal quarterly installments over the following two years."}],"balance_after":0,"derivative":{"exercise_price":12.55,"expiration_date":"2028-01-28","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-24-011170","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124011170/form4.xml","form_type":"4"}},{"id":1603092,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-04T23:54:22.000Z","date":"2024-02-29","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":29.845,"value":298450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.78 to $29.91. The Reporting Person has provided the issuer and will provide any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":21517,"source":{"system":"sec-edgar","filing":"0001140361-24-011170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124011170/form4.xml","form_type":"4"}},{"id":1603091,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-03-04T23:54:22.000Z","date":"2024-02-29","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":12.55,"value":125500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares received upon exercise of a Stock Option."}],"balance_after":31517,"source":{"system":"sec-edgar","filing":"0001140361-24-011170","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124011170/form4.xml","form_type":"4"}},{"id":1629228,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T01:54:29.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":24545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option represents a right to purchase a total of 24,545 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":24545,"derivative":{"exercise_price":30.01,"expiration_date":"2034-02-16","underlying":"Common Stock","underlying_shares":24545},"source":{"system":"sec-edgar","filing":"0001140361-24-008888","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124008888/form4.xml","form_type":"4"}},{"id":1629227,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:29.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":8322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"security","element":"securityTitle","label":"F4","text":"Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 16, 2025, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":21517,"source":{"system":"sec-edgar","filing":"0001140361-24-008888","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124008888/form4.xml","form_type":"4"}},{"id":1629226,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-22T01:54:29.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":3238,"price":29.838,"value":96615.444,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The shares beneficially owned by the reporting person are subject to a lock-up agreement dated September 12, 2023 (the \"Lock-Up Agreement\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F3","text":"The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."}],"balance_after":13195,"source":{"system":"sec-edgar","filing":"0001140361-24-008888","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124008888/form4.xml","form_type":"4"}},{"id":1638231,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:43.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":5549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":10159,"derivative":{"underlying":"Common Stock","underlying_shares":5549},"source":{"system":"sec-edgar","filing":"0001140361-24-008357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124008357/form4.xml","form_type":"4"}},{"id":1638230,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T21:05:43.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":2903,"derivative":{"underlying":"Common Stock","underlying_shares":725},"source":{"system":"sec-edgar","filing":"0001140361-24-008357","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124008357/form4.xml","form_type":"4"}},{"id":1638229,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-16T21:05:43.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":6274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":16433,"source":{"system":"sec-edgar","filing":"0001140361-24-008357","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124008357/form4.xml","form_type":"4"}},{"id":1673012,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-23T21:22:09.000Z","date":"2024-01-22","kind":"sale","planned":false,"acquired":false,"shares":638,"price":27.203,"value":17355.514,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."}],"balance_after":10159,"source":{"system":"sec-edgar","filing":"0001140361-24-003421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124003421/form4.xml","form_type":"4"}},{"id":1674189,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2024-01-22T21:05:30.000Z","date":"2024-01-18","kind":"exercise","planned":false,"acquired":false,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":7932,"derivative":{"underlying":"Common Stock","underlying_shares":1586},"source":{"system":"sec-edgar","filing":"0001140361-24-003111","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124003111/form4.xml","form_type":"4"}},{"id":1674188,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-22T21:05:30.000Z","date":"2024-01-18","kind":"exercise","planned":false,"acquired":true,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":10797,"source":{"system":"sec-edgar","filing":"0001140361-24-003111","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036124003111/form4.xml","form_type":"4"}},{"id":1739052,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-11-16T23:58:15.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":false,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":3628,"derivative":{"underlying":"Common Stock","underlying_shares":725},"source":{"system":"sec-edgar","filing":"0001140361-23-053705","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123053705/form4.xml","form_type":"4"}},{"id":1739051,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-11-16T23:58:15.000Z","date":"2023-11-14","kind":"exercise","planned":false,"acquired":true,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":9485,"source":{"system":"sec-edgar","filing":"0001140361-23-053705","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123053705/form4.xml","form_type":"4"}},{"id":1755202,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-25T13:38:05.000Z","date":"2023-10-20","kind":"sale","planned":false,"acquired":false,"shares":564,"price":17.062,"value":9622.968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of common stock were sold by the Reporting Person pursuant to an exemption to the Lock-Up Agreement in order to pay tax withholding obligations in connection with the vesting of RSUs. Notwithstanding the sales reported on this Form 4, the securities beneficially owned by the reporting person remain subject to the terms of the Lock-Up Agreement."}],"balance_after":8760,"source":{"system":"sec-edgar","filing":"0001140361-23-049426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123049426/form4.xml","form_type":"4"}},{"id":1756905,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-10-20T22:37:46.000Z","date":"2023-10-18","kind":"exercise","planned":false,"acquired":false,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":9518,"derivative":{"underlying":"Common Stock","underlying_shares":1586},"source":{"system":"sec-edgar","filing":"0001140361-23-049079","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123049079/form4.xml","form_type":"4/A","original_submission_date":"2023-02-22"}},{"id":1756904,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-20T22:37:46.000Z","date":"2023-10-18","kind":"exercise","planned":false,"acquired":true,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares of Common Stock received upon vesting of an RSU award."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares of Common Stock received upon vesting of an RSU award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The error in the original Form 4 was carried through in Column 5 of Table 1 in subsequent filings but is corrected in the total amount of securities owned in this Form 4."}],"balance_after":9324,"source":{"system":"sec-edgar","filing":"0001140361-23-049079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123049079/form4.xml","form_type":"4/A","original_submission_date":"2023-02-22"}},{"id":1756903,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-10-20T22:37:46.000Z","date":"2023-02-17","kind":"sale","planned":false,"acquired":false,"shares":1076,"price":19.06,"value":20508.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 corrects an error on the original Form 4 filed on February 22, 2023. The original Form 4 stated that the Reporting Person sold 1,244 shares of the Issuer's common stock to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. The Reporting Person sold 1,076 shares of the Issuer's common stock on February 17, 2023 to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 corrects an error on the original Form 4 filed on February 22, 2023. The original Form 4 stated that the Reporting Person sold 1,244 shares of the Issuer's common stock to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person. The Reporting Person sold 1,076 shares of the Issuer's common stock on February 17, 2023 to cover tax withholding obligations in connection with the vesting of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The error in the original Form 4 was carried through in Column 5 of Table 1 in subsequent filings but is corrected in the total amount of securities owned in this Form 4."}],"balance_after":1782,"source":{"system":"sec-edgar","filing":"0001140361-23-049079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123049079/form4.xml","form_type":"4/A","original_submission_date":"2023-02-22"}},{"id":1800757,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-21T20:05:36.000Z","date":"2023-08-17","kind":"sale","planned":false,"acquired":false,"shares":284,"price":15.471,"value":4393.764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":5570,"source":{"system":"sec-edgar","filing":"0001140361-23-040693","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123040693/form4.xml","form_type":"4"}},{"id":1807338,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-08-15T20:17:08.000Z","date":"2023-08-14","kind":"exercise","planned":false,"acquired":false,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":4353,"derivative":{"underlying":"Common Stock","underlying_shares":725},"source":{"system":"sec-edgar","filing":"0001140361-23-039905","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123039905/form4.xml","form_type":"4"}},{"id":1807337,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-08-15T20:17:08.000Z","date":"2023-08-14","kind":"exercise","planned":false,"acquired":true,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":7854,"source":{"system":"sec-edgar","filing":"0001140361-23-039905","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123039905/form4.xml","form_type":"4"}},{"id":1824145,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-24T20:05:14.000Z","date":"2023-07-20","kind":"sale","planned":false,"acquired":false,"shares":573,"price":19.033,"value":10905.909,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":7129,"source":{"system":"sec-edgar","filing":"0001140361-23-035859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123035859/form4.xml","form_type":"4"}},{"id":1825829,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-07-20T20:05:15.000Z","date":"2023-07-18","kind":"exercise","planned":false,"acquired":false,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":11104,"derivative":{"underlying":"Common Stock","underlying_shares":1586},"source":{"system":"sec-edgar","filing":"0001140361-23-035428","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123035428/form4.xml","form_type":"4"}},{"id":1825828,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-07-20T20:05:15.000Z","date":"2023-07-18","kind":"exercise","planned":false,"acquired":true,"shares":1586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":7702,"source":{"system":"sec-edgar","filing":"0001140361-23-035428","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123035428/form4.xml","form_type":"4"}},{"id":1884614,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-19T20:05:30.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":245,"price":21.375,"value":5236.875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."}],"balance_after":6116,"source":{"system":"sec-edgar","filing":"0001140361-23-025741","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123025741/form4.xml","form_type":"4"}},{"id":1891520,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-05-17T00:01:55.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":false,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":5078,"derivative":{"underlying":"Common Stock","underlying_shares":725},"source":{"system":"sec-edgar","filing":"0001140361-23-025132","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123025132/form4.xml","form_type":"4"}},{"id":1891519,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-05-17T00:01:55.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":true,"shares":725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":6361,"source":{"system":"sec-edgar","filing":"0001140361-23-025132","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123025132/form4.xml","form_type":"4"}},{"id":1914153,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-25T22:33:13.000Z","date":"2023-04-21","kind":"sale","planned":false,"acquired":false,"shares":2342,"price":18.65,"value":43678.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs received by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple brokered trades at prices ranging from $18.55 to $18.88. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5636,"source":{"system":"sec-edgar","filing":"0001140361-23-020312","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123020312/form4.xml","form_type":"4"}},{"id":1916463,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-04-20T22:34:38.000Z","date":"2023-04-18","kind":"exercise","planned":false,"acquired":true,"shares":6364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such RSUs became fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":12670,"derivative":{"underlying":"Common Stock","underlying_shares":6364},"source":{"system":"sec-edgar","filing":"0001140361-23-019447","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123019447/form4.xml","form_type":"4"}},{"id":1916462,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-04-20T22:34:38.000Z","date":"2023-04-18","kind":"exercise","planned":false,"acquired":true,"shares":6364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit (\"RSU\") award."}],"balance_after":7978,"source":{"system":"sec-edgar","filing":"0001140361-23-019447","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123019447/form4.xml","form_type":"4"}},{"id":1999876,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-23T00:28:04.000Z","date":"2023-02-17","kind":"sale","acquired":false,"shares":1244,"price":19.06,"value":23710.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple brokered trades at prices ranging from $18.735 to $19.195. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1614,"source":{"system":"sec-edgar","filing":"0001140361-23-008103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123008103/form4.xml","form_type":"4"}},{"id":1999875,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T00:25:47.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"One-third (1/3) of such restricted stock units became fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":5803,"derivative":{"underlying":"Common Stock","underlying_shares":2858},"source":{"system":"sec-edgar","filing":"0001140361-23-008099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123008099/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999874,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-23T00:25:47.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":16616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":16616,"derivative":{"underlying":"Common Stock","underlying_shares":16616},"source":{"system":"sec-edgar","filing":"0001140361-23-008099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123008099/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999873,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-23T00:25:47.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":49798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents a right to purchase a total of 49,798 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":49798,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":49798},"source":{"system":"sec-edgar","filing":"0001140361-23-008099","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123008099/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":1999872,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-02-23T00:25:47.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":2858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The original Form 4, filed on February 16, 2023, is being amended by this amendment to include the vesting of restricted stock units that took place on February 14, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock received upon vesting of a restricted stock unit award."}],"balance_after":2858,"source":{"system":"sec-edgar","filing":"0001140361-23-008099","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123008099/form4.xml","form_type":"4/A","original_submission_date":"2023-02-16"}},{"id":2010982,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2023-02-16T21:45:43.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":16616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":16616,"derivative":{"underlying":"Common Stock","underlying_shares":16616},"source":{"system":"sec-edgar","filing":"0001140361-23-007485","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123007485/form4.xml","form_type":"4"}},{"id":2010981,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-16T21:45:43.000Z","date":"2023-02-14","kind":"grant","acquired":true,"shares":49798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 49,798 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":49798,"derivative":{"exercise_price":20.04,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":49798},"source":{"system":"sec-edgar","filing":"0001140361-23-007485","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036123007485/form4.xml","form_type":"4"}},{"id":2184227,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-08-16T21:27:57.000Z","date":"2022-08-12","kind":"grant","acquired":true,"shares":14310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will become fully vested on August 12, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will become fully vested on August 12, 2025."}],"balance_after":14310,"derivative":{"underlying":"Common Stock","underlying_shares":14310},"source":{"system":"sec-edgar","filing":"0001140361-22-029890","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036122029890/form4.xml","form_type":"4"}},{"id":2293923,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-04-20T20:06:34.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":19054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":19054,"derivative":{"underlying":"Common Stock","underlying_shares":19054},"source":{"system":"sec-edgar","filing":"0001140361-22-015162","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036122015162/form4.xml","form_type":"4"}},{"id":2293922,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-20T20:06:34.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":28910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 28,910 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on April 18, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":28910,"derivative":{"exercise_price":13.12,"expiration_date":"2032-04-17","underlying":"Common Stock","underlying_shares":28910},"source":{"system":"sec-edgar","filing":"0001140361-22-015162","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036122015162/form4.xml","form_type":"4"}},{"id":2391913,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-02-17T02:02:38.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":8661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":8661,"derivative":{"underlying":"Common Stock","underlying_shares":8661},"source":{"system":"sec-edgar","filing":"0001140361-22-005824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036122005824/form4.xml","form_type":"4"}},{"id":2391912,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T02:02:38.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":27003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,003 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2023, with the remaining shares vesting in equal quarterly installments over the following two years."}],"balance_after":27003,"derivative":{"exercise_price":20,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":27003},"source":{"system":"sec-edgar","filing":"0001140361-22-005824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036122005824/form4.xml","form_type":"4"}},{"id":2874502,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T01:44:44.000Z","date":"2021-02-04","kind":"disposition_to_issuer","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 4, 2022, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":18000,"derivative":{"exercise_price":62.32,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001140361-21-003784","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036121003784/form4.xml","form_type":"4"}},{"id":3067514,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-06T00:55:41.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on August 3, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":18000,"derivative":{"exercise_price":24.82,"expiration_date":"2030-08-03","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001140361-20-017591","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000114036120017591/form4.xml","form_type":"4"}},{"id":3282161,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T22:06:14.000Z","date":"2020-02-10","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase a total of 2,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 10, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":2000,"derivative":{"exercise_price":23.89,"expiration_date":"2030-02-10","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-20-008012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000120919120008012/doc4.xml","form_type":"4"}},{"id":3282160,"issuer":{"id":5627,"kind":"organization","name":"ROCKET PHARMACEUTICALS, INC.","symbol":"RCKT"},"owners":[{"id":43512,"kind":"person","name":"Militello John","position":1,"cik":"0001662170","reported_name":"Militello John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T22:06:14.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 6, 2021, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer."}],"balance_after":20000,"derivative":{"exercise_price":22.72,"expiration_date":"2030-02-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-008012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662170/000120919120008012/doc4.xml","form_type":"4"}}],"next_cursor":"2020-02-10T22:06:14.000000Z,3282160"}